Breast cancer vaccine BP1 7 (Biomira)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBreast cancer vaccine BP1 7 (Biomira)
Drug Alias NameCancer vaccine BP1 7 - BiomiraBP1 7-KLHBLP16
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionAnti-MUC1Immunostimulants
TargetsMucin-1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomira
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomira
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A